AJMC Staff

President Biden orders states to broaden vaccine eligibility by May 1; new data from Novavax, Pfizer point to high vaccine efficacy; Supreme Court will not hear arguments on Medicaid work requirements.

Today marks the 1-year anniversary of the World Health Organization declaring COVID-19 a pandemic; President Biden orders 100 million more Johnson & Johnson vaccines; 2020 saw a 15% increase in the US death rate.

Alaska removes COVID-19 vaccine eligibility restrictions; Affordable Care Act (ACA) health plan subsidies could increase under new relief bill; HHS is reviewing CDC COVID-19–related race and ethnicity data reporting.

Many people who experience long-term symptoms from COVID-19 were asymptomatic when initially infected; COVID-19 patients with intellectual disabilities were shown to be more susceptible to hospitalization and death; the Pfizer/BioNTech vaccine neutralizes the more contagious variant first identified in Brazil.

The House of Representatives is expected to grant final approval to the COVID-19 relief bill by Tuesday; FDA probes major baby food companies selling products containing unsafe levels of toxic heavy metals; FDA issues emergency authorization for novel test to detect past COVID-19 infection.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Asthma and immunology specialists responding to a survey about physical activity for patients with asthma were mostly unaware of any guidelines but seemed willing to learn more about how to incorporate them into practice.

The FDA approved axicabtagene ciloleucel (Yescarta) for the treatment of adult patients with relapsed or refractory follicular lymphoma following 2 or more lines of systemic therapy.

A study finds rates of pediatric COVID-19 cases in Mississippi were largely underestimated; countries with more overweight citizens report more COVID-19 deaths; Senate acts to pass $1.9 trillion relief package.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A lack of pharmacies in rural America could complicate COVID-19 vaccine rollout; over 200,000 Americans enrolled in Affordable Care Act plans during special period; wealthy, older residents in Florida receive COVID-19 vaccines.

States lift some COVID-19 restrictions despite warnings from top health officials; President Biden says all American adults should be able to receive a vaccine by the end of May; report highlights decline in young, middle age adult life expectancy.

The specialization program will teach fundamentals and offer real-world examples of value-based care through an online program.

The disorder known as molybdenum cofactor deficiency (MoCD) Type A presents shortly after birth, often with severe encephalopathy and intractable seizures.

The first batch of Johnson & Johnson’s COVID-19 vaccine will be shipped today to states and pharmacies nationwide; Anthony Fauci, MD, says elementary school-aged children very likely to able to be vaccinated by first quarter 2022; special clinics nationwide try to treat COVID-19 survivors who continue to experience long-term symptoms.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

The peptide-drug conjugate rapidly delivers an alkylating payload into tumor cells.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

More Americans say they are willing to receive a COVID-19 vaccine; 50 million doses have been administered during President Joe Biden's first 5 weeks in office; FDA allows Pfizer vaccine to be stored at standard freezer temperatures.

Outsiders take advantage of a Los Angeles program aimed to aid communities hit hard by COVID-19; Biden plans to send 25 million masks out to Americans; real-world data highlight the efficacy of the Pfizer/BioNTech COVID-19 vaccine.

An FDA committee will discuss emergency use authorization of the coronavirus disease 2019 (COVID-19) vaccine from Johnson & Johnson (J&J); American Cancer Society issues a report on cancer survivor concerns; Tennessee is found to have wasted thousands of vaccine doses.

House Budget Committee advances $1.9 trillion coronavirus disease 2019 (COVID-19) relief bill; FDA will expedite trials examining booster shots against COVID-19 variants; 1 shot of Pfizer/BioNTech's COVID-19 vaccine cuts hospitalization risk by 75%.

Pfizer/BioNTech vaccine shown to prevent most coronavirus disease 2019 (COVID-19)–related deaths or hospitalizations; extreme weather delays 6 million vaccine doses; post-traumatic stress disorder and anxiety seen in COVID-19 survivors.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The Pfizer/BioNTech coronavirus disease 2019 vaccine can be stored at higher temperatures; the Biden administration pledges $4 billion over 2 years to Gavi, the Vaccine Alliance; Medicare payments will soon decrease for hundreds of hospitals.

The coronavirus disease 2019 (COVID-19) pandemic has led to sharp declines in US life expectancy; a new CMS administrator nominee is selected; Biden administration announces funds to combat virus variants.

Novartis is teaming up with the Gates Foundation to develop a gene therapy for sickle cell disease; the World Health Organization reports a drop in global cases of coronavirus disease 2019 (COVID-19); storms hinder vaccine rollout across the United States.

The Affordable Care Act marketplace reopened yesterday for a special enrollment period that will run until May 15; daily US coronavirus infections drop below 100,000 for first time since November; opioid deaths rise significantly amid the pandemic.

British scientists report research linking a UK coronavirus disease 2019 (COVID-19) variant with higher risk of hospitalization and death; polls highlight the partisan gap among Americans willing to be vaccinated against COVID-19; state legislators nationwide are targeting legislation to curb rising drug prices.